Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
A. Loizate Toricaguena, A. Lamiquiz Vallejo, M. J. Dominguez Merru-Urrutia & J. F. Legorburu Escudero. (1991) Tumor-Associated Trypsin Inhibitor (Tati) in Benign and Malignant Gastric Disease. Scandinavian Journal of Clinical and Laboratory Investigation 51:sup207, pages 59-62.
Read now
Read now
J. I. Rayo, J. R. Garcia-Talavera, M. Martin, A. Muñoz & A. Del Cañizo. (1991) Serum Tati Levels and Clinical Correlation in Tumors of the Head and Neck. Scandinavian Journal of Clinical and Laboratory Investigation 51:sup207, pages 33-35.
Read now
Read now
U-H. Stenman, E. Koivunen & O. Itkonen. (1991) Biology and Function of Tumor-Associated Trypsin Inhibitor, Tati. Scandinavian Journal of Clinical and Laboratory Investigation 51:sup207, pages 5-9.
Read now
Read now
Articles from other publishers (11)
Christine Mehner, Alexandra Hockla, Mathew Coban, Benjamin Madden, Rosendo Estrada, Derek C. Radisky & Evette S. Radisky. (2022) Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma. Journal of Biological Chemistry 298:8, pages 102146.
Crossref
Crossref
T. Anitha Sironmani. (2016) Therapeutic Potential of Neem Synthesized Silver Nanoparticles on Human Gastric Cancer Cells <i>in Vitro</i>. World Journal of Nano Science and Engineering 06:02, pages 90-110.
Crossref
Crossref
A Gaber, M Johansson, U-H Stenman, K Hotakainen, F Pontén, B Glimelius, A Bjartell, K Jirström & H Birgisson. (2009) High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. British Journal of Cancer 100:10, pages 1540-1548.
Crossref
Crossref
Zygmunt Mackiewicz, Marko Määttä, Mathias Stenman, Lasse Konttinen, Timo Tervo & Yrjö T. Konttinen. (2006) Collagenolytic Proteinases in Keratoconus. Cornea 25:5, pages 603-610.
Crossref
Crossref
J-P Wiksten, J Lundin, S Nordling, A Kokkola, U-H Stenman & C Haglund. (2005) High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology 46:4, pages 380-388.
Crossref
Crossref
Susan R. Wilson, Sandra Gallagher, Kate Warpeha & Susan J. Hawthorne. (2004) Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptors. The Prostate 60:2, pages 168-174.
Crossref
Crossref
Hiroyuki Yamamoto, Shouhei Iku, Yasushi Adachi, Arisa Imsumran, Hiroaki Taniguchi, Katsuhiko Nosho, Yongfen Min, Shina Horiuchi, Mio Yoshida, Fumio Itoh & Kohzoh Imai. (2003) Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. The Journal of Pathology 199:2, pages 176-184.
Crossref
Crossref
Annukka Lukkonen, Timo Sorsa, Tuula Salo, Taina Tervahartiala, Erkki Koivunen, Lorne Golub, Sanford Simon & Ulf-H�kan Stenman. (2000) Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration. International Journal of Cancer 86:4, pages 577-581.
Crossref
Crossref
Hans Bohe, Måns Bohe, Eva Lundberg, Åsa Polling & Kjell Ohlsson. (1997) Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine. Journal of Gastroenterology 32:5, pages 623-627.
Crossref
Crossref
Jorma Järvisalo, Matti Hakama, Paul Knekt, Ulf-Håkan Stenman, Aila Leino, Lyly Teppo, Jouni Maatela & Arpo Aromaa. (1993) Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening. Cancer 71:6, pages 1982-1988.
Crossref
Crossref
B. Miszczuk-Jamska, M. Merten, O. Guy-Crotte, M. Amouric, F. Clemente, R.A. Schoumacher & C. Figarella. (1991) Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1. FEBS Letters 294:3, pages 175-178.
Crossref
Crossref